Unbiased treatment effect estimates by modeling the disease process of multiple sclerosis

Journal of the Neurological Sciences

Volumn 278, Issue 1-2, 2009, Pages 54-59

  Healy, Brian C ^a,b   Hayden, Douglas L ^b   Sampat, Mehul P ^a   Bakshi, Rohit ^a   Guttmann, Charles R G ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Active inactive disease process; Clinical trials; MRI; Multiple sclerosis; Regression to the mean

Indexed keywords

GADOLINIUM;

ARTICLE; BRAIN DAMAGE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SIMULATION; HUMAN; MULTIPLE SCLEROSIS; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THERAPY EFFECT; TREATMENT OUTCOME;

BRAIN; CLINICAL TRIALS, PHASE I AS TOPIC; CLINICAL TRIALS, PHASE II AS TOPIC; COMPUTER SIMULATION; GADOLINIUM; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; NORMAL DISTRIBUTION; POISSON DISTRIBUTION; TREATMENT OUTCOME;

EID: 58749093190     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.11.013     Document Type: Article

References (20)

1. Kappos L., Moeri D., Radue E., Schoetzau A., Schweikert K., Barkhof F., et al. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Lancet 353 (1999) 964-969
2. Bakshi R., Minagar A., Jaisani Z., and Wolinsky J. Imaging of multiple sclerosis: role in neurotherapeutics. NeuroRx 2 (2005) 277-303
3. McFarland H.F., Frank J.A., Albert P.S., Smith M.E., Martin R., Harris J.O., et al. Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol 32 (1992) 758-766
4. Miller D., Grossman R., Reingold S., and McFarland H. The role of magnetic resonance techniques in understanding and managing multiple sclerosis. Brain 121 (1998) 3-24
5. Sormani M.P., Bruzzi P., Miller D.H., Gasperini C., Barkhof F., and Filippi M. Modelling MRI enhancing lesion counts in multiple sclerosis using a negative binomial model: implications for clinical trials. J Neurol Sci 163 (1999) 74-80
6. Sormani M.P., Miller D.H., Comi G., Barkhof F., Rovaris M., Bruzzi P., et al. Clinical trials in multiple sclerosis monitored with enhanced MRI: new sample size calculations based on large data sets. J Neurol Neurosurg Psychiatry 70 (2001) 494-499
7. Calabresi P.A., Wilterdink J.L., Rogg J.M., Mills P., Webb A., and Whartenby K.A. An open label trial of combination therapy with interferon beta-1a and oral methotrexate in MS. Neurology 58 (2002) 314-317
8. Bar-Or A., Calabresi P.A., Arnold D., Markowitz C., Shafer S., Kasper L.H., et al. Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label phase I trial. Ann Neurol 63 (2008) 395-400
9. McFarland H.F., and Reingold S.C. The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era. Mult Scler 11 (2005) 669-676
10. Zhao Y., Traboulsee A., Petkau J., and Li D. Regression of new gadolinium enhancing lesion activity in relapsing-remitting multiple sclerosis. Neurology 70 (2008) 1092-1097
11. Ederer F. Serum cholesterol changes: effects of diet and regression toward the mean. J Chronic Dis 25 (1972) 277-289
12. Davis C.E. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 104 (1976) 493-498
13. Yudkin P.L., and Stratton I.M. How to deal with regression to the mean in intervention studies. Lancet 347 (1996) 241-243
14. Stigler S.M. Regression towards the mean, historically considered. Stat Methods Med Res 6 (1997) 103-114
15. Lin H.M., and Hughes M.D. Adjusting for regression toward the mean when variables are normally distributed. Stat Methods Med Res 6 (1997) 129-146
16. Cook R.J., and Wei W. Selection effects in randomized trials with count data. Stat Med 21 4 (2002) 515-531
17. Cotton F., Weiner H., Jolesz F., and Guttmann C. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60 (2003) 640-646
18. Fitzmaurice G., Laird N., and Ware J. Applied longitudinal analysis. 2nd ed (2002), Wiley, New York
19. Park C.G., and Shin D.W. An algorithm for generating correlated random variables in a class of infinitely divisible distributions. J Stat Comput Simul 61 (1998) 127-139
20. Piaggio G., Elbourne D.R., Altman D.G., Pocock S.J., Evans S.J.W., and for the CONSORT group. Reporting of noninferiority and equivalence randomized trials. JAMA 295 (2006) 1152-1160